NO330802B1 - Metode for gjenvinning av RNA fra formalin-fiksert paraffin-innstopt vevsprove, metode for kvantitativ maling av genekspresjon av et malgen og metode for maling av niva av malgenekspresjon i en fiksert paraffin-innstopt vevsprove. - Google Patents

Metode for gjenvinning av RNA fra formalin-fiksert paraffin-innstopt vevsprove, metode for kvantitativ maling av genekspresjon av et malgen og metode for maling av niva av malgenekspresjon i en fiksert paraffin-innstopt vevsprove. Download PDF

Info

Publication number: NO330802B1
Authority: NO; Norway
Prior art keywords: rna; sample; expression; approx; tissue sample
Prior art date: 1999-12-20

Application number

NO20022945A

Other languages

English (en)

Norwegian (no)

Other versions

NO20022945D0 (no

NO20022945L (no

Inventor

Kathleen Dananberg

Peter Dananberg

Steven Swenson

Original Assignee

Univ Southern California

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-12-20

Filing date

2002-06-19

Publication date

2011-07-18

2002-06-19 Application filed by Univ Southern California filed Critical Univ Southern California

2002-06-19 Publication of NO20022945D0 publication Critical patent/NO20022945D0/no

2002-08-06 Publication of NO20022945L publication Critical patent/NO20022945L/no

2011-07-18 Publication of NO330802B1 publication Critical patent/NO330802B1/no

Links

238000000034 method Methods 0.000 title claims description 93
230000014509 gene expression Effects 0.000 title claims description 61
238000005259 measurement Methods 0.000 title claims description 4
101150108610 MAL gene Proteins 0.000 title 2
108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 83
108010022394 Threonine synthase Proteins 0.000 claims description 58
102000005497 Thymidylate Synthase Human genes 0.000 claims description 57
239000000523 sample Substances 0.000 claims description 49
108090000623 proteins and genes Proteins 0.000 claims description 31
230000003196 chaotropic effect Effects 0.000 claims description 30
238000010438 heat treatment Methods 0.000 claims description 24
ZJYYHGLJYGJLLN-UHFFFAOYSA-N guanidinium thiocyanate Chemical compound SC#N.NC(N)=N ZJYYHGLJYGJLLN-UHFFFAOYSA-N 0.000 claims description 19
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 16
238000010839 reverse transcription Methods 0.000 claims description 16
239000002299 complementary DNA Substances 0.000 claims description 14
238000011084 recovery Methods 0.000 claims description 13
239000003960 organic solvent Substances 0.000 claims description 12
VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 claims description 11
238000006243 chemical reaction Methods 0.000 claims description 10
108020004999 messenger RNA Proteins 0.000 claims description 7
238000000605 extraction Methods 0.000 claims description 6
238000000746 purification Methods 0.000 claims description 6
230000003321 amplification Effects 0.000 claims description 5
230000008859 change Effects 0.000 claims description 5
238000004587 chromatography analysis Methods 0.000 claims description 5
238000001962 electrophoresis Methods 0.000 claims description 5
238000003199 nucleic acid amplification method Methods 0.000 claims description 5
238000003752 polymerase chain reaction Methods 0.000 claims description 5
239000003638 chemical reducing agent Substances 0.000 claims description 4
238000000265 homogenisation Methods 0.000 claims description 4
238000013467 fragmentation Methods 0.000 claims description 3
238000006062 fragmentation reaction Methods 0.000 claims description 3
PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 claims description 3
-1 guanidinium compound Chemical class 0.000 claims description 3
108020004707 nucleic acids Proteins 0.000 claims description 3
102000039446 nucleic acids Human genes 0.000 claims description 3
150000007523 nucleic acids Chemical class 0.000 claims description 3
108020005187 Oligonucleotide Probes Proteins 0.000 claims description 2
BFMYDTVEBKDAKJ-UHFFFAOYSA-L disodium;(2',7'-dibromo-3',6'-dioxido-3-oxospiro[2-benzofuran-1,9'-xanthene]-4'-yl)mercury;hydrate Chemical compound O.[Na+].[Na+].O1C(=O)C2=CC=CC=C2C21C1=CC(Br)=C([O-])C([Hg])=C1OC1=C2C=C(Br)C([O-])=C1 BFMYDTVEBKDAKJ-UHFFFAOYSA-L 0.000 claims description 2
239000002751 oligonucleotide probe Substances 0.000 claims description 2
238000012869 ethanol precipitation Methods 0.000 claims 1
238000010208 microarray analysis Methods 0.000 claims 1
210000001519 tissue Anatomy 0.000 description 62
239000000243 solution Substances 0.000 description 39
206010028980 Neoplasm Diseases 0.000 description 29
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 28
239000012188 paraffin wax Substances 0.000 description 20
239000008188 pellet Substances 0.000 description 14
GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 12
238000010240 RT-PCR analysis Methods 0.000 description 12
239000003795 chemical substances by application Substances 0.000 description 12
229960002949 fluorouracil Drugs 0.000 description 12
108020004414 DNA Proteins 0.000 description 11
230000004044 response Effects 0.000 description 11
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 10
210000004027 cell Anatomy 0.000 description 10
206010009944 Colon cancer Diseases 0.000 description 9
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 9
101150112897 TS gene Proteins 0.000 description 9
108010085238 Actins Proteins 0.000 description 8
102000004169 proteins and genes Human genes 0.000 description 8
102000007469 Actins Human genes 0.000 description 7
206010027476 Metastases Diseases 0.000 description 7
238000005119 centrifugation Methods 0.000 description 7
238000002560 therapeutic procedure Methods 0.000 description 7
108010037462 Cyclooxygenase 2 Proteins 0.000 description 6
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 6
102100038280 Prostaglandin G/H synthase 2 Human genes 0.000 description 6
108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 6
102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 6
108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 6
210000001072 colon Anatomy 0.000 description 6
208000029742 colonic neoplasm Diseases 0.000 description 6
238000002955 isolation Methods 0.000 description 6
230000009401 metastasis Effects 0.000 description 6
238000001556 precipitation Methods 0.000 description 6
238000003753 real-time PCR Methods 0.000 description 6
FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 6
238000005406 washing Methods 0.000 description 6
239000008096 xylene Substances 0.000 description 6
102100034343 Integrase Human genes 0.000 description 5
CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 5
101710132082 Pyrimidine/purine nucleoside phosphorylase Proteins 0.000 description 5
238000002123 RNA extraction Methods 0.000 description 5
108010092799 RNA-directed DNA polymerase Proteins 0.000 description 5
102000013537 Thymidine Phosphorylase Human genes 0.000 description 5
238000004458 analytical method Methods 0.000 description 5
239000008346 aqueous phase Substances 0.000 description 5
239000012472 biological sample Substances 0.000 description 5
238000001514 detection method Methods 0.000 description 5
230000000694 effects Effects 0.000 description 5
210000004185 liver Anatomy 0.000 description 5
239000002904 solvent Substances 0.000 description 5
239000006228 supernatant Substances 0.000 description 5
VVIAGPKUTFNRDU-UHFFFAOYSA-N 6S-folinic acid Natural products C1NC=2NC(N)=NC(=O)C=2N(C=O)C1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 VVIAGPKUTFNRDU-UHFFFAOYSA-N 0.000 description 4
208000001333 Colorectal Neoplasms Diseases 0.000 description 4
150000001298 alcohols Chemical class 0.000 description 4
239000000872 buffer Substances 0.000 description 4
201000011510 cancer Diseases 0.000 description 4
210000003238 esophagus Anatomy 0.000 description 4
238000002474 experimental method Methods 0.000 description 4
VVIAGPKUTFNRDU-ABLWVSNPSA-N folinic acid Chemical compound C1NC=2NC(N)=NC(=O)C=2N(C=O)C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 VVIAGPKUTFNRDU-ABLWVSNPSA-N 0.000 description 4
235000008191 folinic acid Nutrition 0.000 description 4
239000011672 folinic acid Substances 0.000 description 4
YQOKLYTXVFAUCW-UHFFFAOYSA-N guanidine;isothiocyanic acid Chemical compound N=C=S.NC(N)=N YQOKLYTXVFAUCW-UHFFFAOYSA-N 0.000 description 4
230000016507 interphase Effects 0.000 description 4
PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 4
229960001691 leucovorin Drugs 0.000 description 4
239000000463 material Substances 0.000 description 4
239000012074 organic phase Substances 0.000 description 4
239000012071 phase Substances 0.000 description 4
238000011002 quantification Methods 0.000 description 4
UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
229920002527 Glycogen Polymers 0.000 description 3
108010077895 Sarcosine Proteins 0.000 description 3
YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
229940096919 glycogen Drugs 0.000 description 3
ZRALSGWEFCBTJO-UHFFFAOYSA-O guanidinium Chemical compound NC(N)=[NH2+] ZRALSGWEFCBTJO-UHFFFAOYSA-O 0.000 description 3
238000004255 ion exchange chromatography Methods 0.000 description 3
206010061289 metastatic neoplasm Diseases 0.000 description 3
238000002156 mixing Methods 0.000 description 3
230000001575 pathological effect Effects 0.000 description 3
238000002205 phenol-chloroform extraction Methods 0.000 description 3
NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
229940043230 sarcosine Drugs 0.000 description 3
238000001542 size-exclusion chromatography Methods 0.000 description 3
DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 3
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
206010006187 Breast cancer Diseases 0.000 description 2
208000026310 Breast neoplasm Diseases 0.000 description 2
102100022334 Dihydropyrimidine dehydrogenase [NADP(+)] Human genes 0.000 description 2
108010066455 Dihydrouracil Dehydrogenase (NADP) Proteins 0.000 description 2
102000004190 Enzymes Human genes 0.000 description 2
108090000790 Enzymes Proteins 0.000 description 2
YNQLUTRBYVCPMQ-UHFFFAOYSA-N Ethylbenzene Chemical compound CCC1=CC=CC=C1 YNQLUTRBYVCPMQ-UHFFFAOYSA-N 0.000 description 2
ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical class NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 2
108091034117 Oligonucleotide Proteins 0.000 description 2
VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
239000007983 Tris buffer Substances 0.000 description 2
230000001476 alcoholic effect Effects 0.000 description 2
239000002246 antineoplastic agent Substances 0.000 description 2
239000007864 aqueous solution Substances 0.000 description 2
230000015556 catabolic process Effects 0.000 description 2
229940127089 cytotoxic agent Drugs 0.000 description 2
GYOZYWVXFNDGLU-XLPZGREQSA-N dTMP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)C1 GYOZYWVXFNDGLU-XLPZGREQSA-N 0.000 description 2
JSRLJPSBLDHEIO-SHYZEUOFSA-N dUMP Chemical compound O1[C@H](COP(O)(O)=O)[C@@H](O)C[C@@H]1N1C(=O)NC(=O)C=C1 JSRLJPSBLDHEIO-SHYZEUOFSA-N 0.000 description 2
230000003247 decreasing effect Effects 0.000 description 2
238000006731 degradation reaction Methods 0.000 description 2
238000011161 development Methods 0.000 description 2
201000010099 disease Diseases 0.000 description 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
239000000834 fixative Substances 0.000 description 2
238000001917 fluorescence detection Methods 0.000 description 2
230000002496 gastric effect Effects 0.000 description 2
230000002055 immunohistochemical effect Effects 0.000 description 2
238000002372 labelling Methods 0.000 description 2
239000000203 mixture Substances 0.000 description 2
229920003023 plastic Polymers 0.000 description 2
238000004366 reverse phase liquid chromatography Methods 0.000 description 2
238000010898 silica gel chromatography Methods 0.000 description 2
239000001632 sodium acetate Substances 0.000 description 2
235000017281 sodium acetate Nutrition 0.000 description 2
238000007619 statistical method Methods 0.000 description 2
238000001356 surgical procedure Methods 0.000 description 2
RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
WAVYAFBQOXCGSZ-UHFFFAOYSA-N 2-fluoropyrimidine Chemical compound FC1=NC=CC=N1 WAVYAFBQOXCGSZ-UHFFFAOYSA-N 0.000 description 1
FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
101150071146 COX2 gene Proteins 0.000 description 1
101100114534 Caenorhabditis elegans ctc-2 gene Proteins 0.000 description 1
230000006820 DNA synthesis Effects 0.000 description 1
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
208000000461 Esophageal Neoplasms Diseases 0.000 description 1
SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical class CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 1
108020004711 Nucleic Acid Probes Proteins 0.000 description 1
206010030155 Oesophageal carcinoma Diseases 0.000 description 1
238000012408 PCR amplification Methods 0.000 description 1
101150000187 PTGS2 gene Proteins 0.000 description 1
108010010677 Phosphodiesterase I Proteins 0.000 description 1
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
108010006785 Taq Polymerase Proteins 0.000 description 1
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
230000009471 action Effects 0.000 description 1
230000001154 acute effect Effects 0.000 description 1
230000002411 adverse Effects 0.000 description 1
238000000246 agarose gel electrophoresis Methods 0.000 description 1
150000001299 aldehydes Chemical class 0.000 description 1
125000000129 anionic group Chemical group 0.000 description 1
150000001450 anions Chemical class 0.000 description 1
230000008901 benefit Effects 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
210000000481 breast Anatomy 0.000 description 1
239000004202 carbamide Substances 0.000 description 1
230000030833 cell death Effects 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
238000002512 chemotherapy Methods 0.000 description 1
229940044683 chemotherapy drug Drugs 0.000 description 1
YTRQFSDWAXHJCC-UHFFFAOYSA-N chloroform;phenol Chemical compound ClC(Cl)Cl.OC1=CC=CC=C1 YTRQFSDWAXHJCC-UHFFFAOYSA-N 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
238000011109 contamination Methods 0.000 description 1
239000002254 cytotoxic agent Substances 0.000 description 1
231100000599 cytotoxic agent Toxicity 0.000 description 1
238000003745 diagnosis Methods 0.000 description 1
229940079593 drug Drugs 0.000 description 1
239000003814 drug Substances 0.000 description 1
210000003989 endothelium vascular Anatomy 0.000 description 1
201000004101 esophageal cancer Diseases 0.000 description 1
239000004052 folic acid antagonist Substances 0.000 description 1
239000011521 glass Substances 0.000 description 1
239000003102 growth factor Substances 0.000 description 1
150000002357 guanidines Chemical class 0.000 description 1
210000003128 head Anatomy 0.000 description 1
208000014829 head and neck neoplasm Diseases 0.000 description 1
210000005260 human cell Anatomy 0.000 description 1
238000009396 hybridization Methods 0.000 description 1
230000036571 hydration Effects 0.000 description 1
238000006703 hydration reaction Methods 0.000 description 1
238000007654 immersion Methods 0.000 description 1
238000003364 immunohistochemistry Methods 0.000 description 1
230000006698 induction Effects 0.000 description 1
230000003834 intracellular effect Effects 0.000 description 1
238000011835 investigation Methods 0.000 description 1
UWKQSNNFCGGAFS-XIFFEERXSA-N irinotecan Chemical compound C1=C2C(CC)=C3CN(C(C4=C([C@@](C(=O)OC4)(O)CC)C=4)=O)C=4C3=NC2=CC=C1OC(=O)N(CC1)CCC1N1CCCCC1 UWKQSNNFCGGAFS-XIFFEERXSA-N 0.000 description 1
239000007791 liquid phase Substances 0.000 description 1
208000026037 malignant tumor of neck Diseases 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
239000003550 marker Substances 0.000 description 1
238000002844 melting Methods 0.000 description 1
230000008018 melting Effects 0.000 description 1
238000002493 microarray Methods 0.000 description 1
210000004400 mucous membrane Anatomy 0.000 description 1
210000003739 neck Anatomy 0.000 description 1
208000025402 neoplasm of esophagus Diseases 0.000 description 1
210000005170 neoplastic cell Anatomy 0.000 description 1
239000002853 nucleic acid probe Substances 0.000 description 1
230000002018 overexpression Effects 0.000 description 1
230000007170 pathology Effects 0.000 description 1
239000013610 patient sample Substances 0.000 description 1
230000002974 pharmacogenomic effect Effects 0.000 description 1
238000005191 phase separation Methods 0.000 description 1
238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
238000007692 polyacrylamide-agarose gel electrophoresis Methods 0.000 description 1
ZNNZYHKDIALBAK-UHFFFAOYSA-M potassium thiocyanate Chemical compound [K+].[S-]C#N ZNNZYHKDIALBAK-UHFFFAOYSA-M 0.000 description 1
229940116357 potassium thiocyanate Drugs 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
239000000047 product Substances 0.000 description 1
BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical class CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
239000002719 pyrimidine nucleotide Substances 0.000 description 1
150000003230 pyrimidines Chemical class 0.000 description 1
238000011155 quantitative monitoring Methods 0.000 description 1
230000000306 recurrent effect Effects 0.000 description 1
230000002829 reductive effect Effects 0.000 description 1
238000006485 reductive methylation reaction Methods 0.000 description 1
230000001105 regulatory effect Effects 0.000 description 1
230000010076 replication Effects 0.000 description 1
239000003161 ribonuclease inhibitor Substances 0.000 description 1
208000037921 secondary disease Diseases 0.000 description 1
230000035945 sensitivity Effects 0.000 description 1
239000000741 silica gel Substances 0.000 description 1
229910002027 silica gel Inorganic materials 0.000 description 1
239000002356 single layer Substances 0.000 description 1
238000010561 standard procedure Methods 0.000 description 1
238000003860 storage Methods 0.000 description 1
239000000725 suspension Substances 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
230000008685 targeting Effects 0.000 description 1
238000012360 testing method Methods 0.000 description 1
ABZLKHKQJHEPAX-UHFFFAOYSA-N tetramethylrhodamine Chemical compound C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C([O-])=O ABZLKHKQJHEPAX-UHFFFAOYSA-N 0.000 description 1
229940113082 thymine Drugs 0.000 description 1
239000000439 tumor marker Substances 0.000 description 1
238000010792 warming Methods 0.000 description 1
150000003738 xylenes Chemical class 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Genetics & Genomics (AREA)
Biomedical Technology (AREA)
Organic Chemistry (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Plant Pathology (AREA)
Biophysics (AREA)
Microbiology (AREA)
Physics & Mathematics (AREA)
Crystallography & Structural Chemistry (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
Analytical Chemistry (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Investigating Or Analysing Biological Materials (AREA)
Peptides Or Proteins (AREA)

NO20022945A 1999-12-20 2002-06-19 Metode for gjenvinning av RNA fra formalin-fiksert paraffin-innstopt vevsprove, metode for kvantitativ maling av genekspresjon av et malgen og metode for maling av niva av malgenekspresjon i en fiksert paraffin-innstopt vevsprove. NO330802B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US09/469,338 US6248535B1 (en)	1999-12-20	1999-12-20	Method for isolation of RNA from formalin-fixed paraffin-embedded tissue specimens
PCT/US2000/030012 WO2001046402A1 (en)	1999-12-20	2000-10-31	Method for isolation of rna from formalin-fixed paraffin-embedded tissue specimens

Publications (3)

Publication Number	Publication Date
NO20022945D0 NO20022945D0 (no)	2002-06-19
NO20022945L NO20022945L (no)	2002-08-06
NO330802B1 true NO330802B1 (no)	2011-07-18

Family

ID=23863395

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20022945A NO330802B1 (no)	1999-12-20	2002-06-19	Metode for gjenvinning av RNA fra formalin-fiksert paraffin-innstopt vevsprove, metode for kvantitativ maling av genekspresjon av et malgen og metode for maling av niva av malgenekspresjon i en fiksert paraffin-innstopt vevsprove.

Country Status (20)

Country	Link
US (8)	US6248535B1 (es)
EP (3)	EP1743939B1 (es)
JP (1)	JP2003525033A (es)
KR (1)	KR100723328B1 (es)
CN (2)	CN1269959C (es)
AR (1)	AR027036A1 (es)
AT (2)	ATE349518T1 (es)
AU (2)	AU784565C (es)
BR (1)	BR0016569A (es)
CA (1)	CA2394618C (es)
DE (1)	DE60032634T2 (es)
DK (1)	DK1743939T3 (es)
EA (2)	EA008832B1 (es)
ES (1)	ES2373149T3 (es)
HK (2)	HK1055446A1 (es)
IL (2)	IL150116A0 (es)
MX (1)	MXPA02006145A (es)
NO (1)	NO330802B1 (es)
TW (1)	TWI277652B (es)
WO (1)	WO2001046402A1 (es)

Families Citing this family (218)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU746497B2 (en) *	1997-08-20	2002-05-02	University Of Miami	A high quality, continuous throughput, tissue fixation-dehydration-fat removal-impregnation method
US6793890B2 (en)	1997-08-20	2004-09-21	The University Of Miami	Rapid tissue processor
US6960439B2 (en)	1999-06-28	2005-11-01	Source Precision Medicine, Inc.	Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles
US6248535B1 (en) *	1999-12-20	2001-06-19	University Of Southern California	Method for isolation of RNA from formalin-fixed paraffin-embedded tissue specimens
US20060166227A1 (en) *	2000-06-20	2006-07-27	Stephen Kingsmore	Protein expression profiling
US7049059B2 (en) *	2000-12-01	2006-05-23	Response Genetics, Inc.	Method of determining a chemotherapeutic regimen based on ERCC1 and TS expression
US20020142328A1 (en) *	2000-12-01	2002-10-03	Danenberg Kathleen D.	Method of determining a chemotherapeutic regimen by assaying gene expression in primary tumors
MX2008005896A (es) *	2000-12-01	2009-03-03	Response Genetics Inc	Metodo in vitro para predecir la sensibilidad de un tumor a un regimen quimioterapico.
US6582919B2 (en)	2001-06-11	2003-06-24	Response Genetics, Inc.	Method of determining epidermal growth factor receptor and HER2-neu gene expression and correlation of levels thereof with survival rates
US6602670B2 (en) *	2000-12-01	2003-08-05	Response Genetics, Inc.	Method of determining a chemotherapeutic regimen based on ERCC1 expression
US6518416B1 (en)	2000-12-01	2003-02-11	Response Genetics, Inc.	Method of determining a chemotherapeutic regimen based on ERCC1 expression
US6956111B2 (en)	2001-03-02	2005-10-18	Response Genetics, Inc.	Method of determining dihydropyrimidine dehydrogenase gene expression
US6686155B2 (en) *	2001-06-14	2004-02-03	Response Genetics, Inc.	Method of determining a chemotherapeutic regimen based on glutathione-S-transferase pi expression
US20040091857A1 (en) *	2001-07-20	2004-05-13	Nallur Girish N.	Gene expression profiling
ES2636974T3 (es) *	2001-10-12	2017-10-10	Becton, Dickinson And Company	Aparato de tipo cesta para el transporte de muestras biológicas
AU2002340158B8 (en)	2001-10-12	2009-06-11	Becton, Dickinson And Company	Method and apparatus for transporting biological samples
CA2466502A1 (en)	2001-11-09	2003-05-15	Source Precision Medicine, Inc.	Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles
US7553619B2 (en) *	2002-02-08	2009-06-30	Qiagen Gmbh	Detection method using dissociated rolling circle amplification
EP2799555B1 (en) *	2002-03-13	2017-02-22	Genomic Health, Inc.	Gene expression profiling in biopsied tumor tissues
EP2385139A1 (en)	2002-07-31	2011-11-09	University of Southern California	Polymorphisms for predicting disease and treatment outcome
CN100374576C (zh) *	2002-10-11	2008-03-12	阿克丘勒斯生物科学股份有限公司	来自ffpe样品的基因表达分布图
US7364846B2 (en) *	2002-10-11	2008-04-29	Molecular Devices Corporation	Gene expression profiling from FFPE samples
EP1572105B1 (en) *	2002-11-14	2011-08-31	John Wayne Cancer Institute	Detection of micro metastasis of melanoma and breast cancer in paraffin-embedded tumor draining lymph nodes by multimaker quantitative rt-pcr
US8039218B2 (en) *	2002-11-14	2011-10-18	John Wayne Cancer Institute	Detection of cancer cells in body fluids
CA2506066A1 (en)	2002-11-15	2004-06-03	Genomic Health, Inc.	Gene expression profiling of egfr positive cancer
US9487823B2 (en)	2002-12-20	2016-11-08	Qiagen Gmbh	Nucleic acid amplification
US20040231909A1 (en)	2003-01-15	2004-11-25	Tai-Yang Luh	Motorized vehicle having forward and backward differential structure
EP1597391B1 (en) *	2003-02-20	2008-10-29	Genomic Health, Inc.	Use of intronic rna to measure gene expression
WO2004080579A2 (en)	2003-03-10	2004-09-23	Expression Pathology, Inc.	Liquid tissue preparation from histopatologically processed biological samples, tissues and cells
US8043834B2 (en)	2003-03-31	2011-10-25	Qiagen Gmbh	Universal reagents for rolling circle amplification and methods of use
US7267950B2 (en) *	2003-05-01	2007-09-11	Veridex, Lcc	Rapid extraction of RNA from cells and tissues
EP1636380A2 (en) *	2003-05-30	2006-03-22	Genomic Health, Inc.	Gene expression markers for response to egfr inhibitor drugs
US20040248103A1 (en) *	2003-06-04	2004-12-09	Feaver William John	Proximity-mediated rolling circle amplification
JP4680898B2 (ja)	2003-06-24	2011-05-11	ジェノミックヘルス，インコーポレイテッド	癌再発の可能性の予測
ES2905579T3 (es) *	2003-07-10	2022-04-11	Genomic Health Inc	Algoritmo del perfil de expresión y prueba para el pronóstico de la recaída del cáncer de mama
US8062897B2 (en)	2003-07-21	2011-11-22	Aureon Laboratories, Inc.	Diagnostic histopathology using multiplex gene expression FISH
WO2005054466A2 (en) *	2003-07-25	2005-06-16	Ambion, Inc.	Methods and compositions for preparing rna from a fixed sample
US20050059024A1 (en)	2003-07-25	2005-03-17	Ambion, Inc.	Methods and compositions for isolating small RNA molecules
US20050042660A1 (en) *	2003-07-31	2005-02-24	Hall Gerald Edward	Devices and methods for isolating RNA
WO2005012487A2 (en) *	2003-08-01	2005-02-10	Invitrogen Corporation	Compositions and methods for preparing short rna molecules and other nucleic acids
WO2005040396A2 (en) *	2003-10-16	2005-05-06	Genomic Health, Inc.	qRT-PCR ASSAY SYSTEM FOR GENE EXPRESSION PROFILING
CA2543043C (en) *	2003-10-24	2013-09-17	The University Of Miami	Simplified tissue processing
EP1689858B1 (en)	2003-11-13	2013-05-15	University Of Georgia Research Foundation, Inc.	Methods of characterizing infectious bursal disease virus
WO2005064019A2 (en) *	2003-12-23	2005-07-14	Genomic Health, Inc.	Universal amplification of fragmented rna
ES2550614T3 (es)	2004-04-09	2015-11-11	Genomic Health, Inc.	Marcadores de expresión génica para predecir la respuesta a la quimioterapia
US7794932B2 (en)	2004-04-16	2010-09-14	Piotr Chomczynski	Reagents and methods for isolation of purified RNA
US7588890B2 (en) *	2004-04-16	2009-09-15	Wei-Sing Chu	Device for extracting biological molecules from tissue specimens and methods for preparing the same
US20050239055A1 (en) *	2004-04-22	2005-10-27	Mariani Brian D	Enterovirus primers and probes
US7332597B2 (en) *	2004-06-28	2008-02-19	University Of Kentucky Research Foundation	Primers and probe to identify mycobacterium tuberculosis complex
EP1774039A4 (en)	2004-07-01	2009-07-08	Univ Southern California	GENETIC MARKERS FOR PREDICTING DISEASES AND THERAPEUTIC RESULTS
US20060099605A1 (en) *	2004-11-11	2006-05-11	Hall Gerald E Jr	Devices and methods for isolating RNA
EP2458015B1 (en)	2004-09-30	2015-12-23	Epigenomics AG	Method for providing DNA fragments derived from an archived sample
DE102004047772B4 (de) *	2004-09-30	2018-12-13	Infineon Technologies Ag	Lateraler Halbleitertransistor
AU2005304824B2 (en)	2004-11-05	2011-12-22	Genomic Health, Inc.	Predicting response to chemotherapy using gene expression markers
ATE550440T1 (de) *	2004-11-05	2012-04-15	Genomic Health Inc	Molekulare indikatoren für brustkrebsprognose und vorhersage des ansprechens auf eine behandlung
US20060141481A1 (en) *	2004-12-27	2006-06-29	Mariani Brian D	HSV-1 and HSV-2 primers and probes
US7541144B2 (en) *	2005-01-31	2009-06-02	Agilent Technologies, Inc.	RNA labeling method
US8309303B2 (en)	2005-04-01	2012-11-13	Qiagen Gmbh	Reverse transcription and amplification of RNA with simultaneous degradation of DNA
US7449297B2 (en) *	2005-04-14	2008-11-11	Euclid Diagnostics Llc	Methods of copying the methylation pattern of DNA during isothermal amplification and microarrays
EP2204454A1 (en) *	2005-05-04	2010-07-07	University of South Florida	Predicting treatment response in cancer subjects
US20060270843A1 (en) *	2005-05-26	2006-11-30	Hall Gerald E Jr	Methods for isolation of nucleic acids
US20060269929A1 (en) *	2005-05-26	2006-11-30	Hall Gerald E Jr	Methods and kits for DNA purification on polymeric membranes at low ionic strength
US7544471B2 (en)	2005-07-30	2009-06-09	Agilent Technologies, Inc.	Preparing RNA from a wax-embedded tissue specimen
US20070054168A1 (en) *	2005-09-06	2007-03-08	Hao Chang	Zinc/air cell
EP1762627A1 (de)	2005-09-09	2007-03-14	Qiagen GmbH	Verfahren zur Aktivierung einer Nukleinsäure für eine Polymerase-Reaktion
EP1777291A1 (en) *	2005-10-20	2007-04-25	Fundacion para la Investigacion Clinica y Molecular del Cancer de Pulmon	Method for the isolation of mRNA from formalin fixed, paraffin-embedded tissue
US20070092883A1 (en) *	2005-10-26	2007-04-26	De Luwe Hoek Octrooien B.V.	Methylation specific multiplex ligation-dependent probe amplification (MS-MLPA)
DE102005060738A1 (de) *	2005-12-16	2007-06-21	Qiagen Gmbh	Verfahren zur Extraktion von Biomolekülen aus fixierten Geweben
CN100366632C (zh) *	2005-12-28	2008-02-06	南方医科大学	一种石蜡包埋组织提取蛋白质的方法
CA2667521A1 (en) *	2006-10-27	2008-05-15	George Mason Intellectual Properties, Inc.	Assay for metastatic colorectal cancer
ES2365447T3 (es) *	2007-05-03	2011-10-05	Roche Diagnostics Gmbh	Cuantificación del arnm de células individuales con rt-pcr en tiempo real.
WO2008157316A1 (en) *	2007-06-14	2008-12-24	Creighton University	Improved method for rna isolation
ES2401475T3 (es) *	2007-06-15	2013-04-19	University Of South Florida	Métodos de diagnóstico y tratamiento del cáncer
JP2010530761A (ja)	2007-06-22	2010-09-16	レスポンスジェネティクス，インコーポレイティド	固定されたサンプルからの長い断片ｒｎａの分離方法
AU2008323701B2 (en)	2007-11-07	2015-03-26	Genentech, Inc	Methods and compositions for assessing responsiveness of B-cell lymphoma to treatment with anti-CD40 antibodies
EP2262893B1 (en) *	2008-04-15	2013-04-24	Universität Bern	Method for optimized isolation of rna from fixed tissue
US20090298172A1 (en) *	2008-05-28	2009-12-03	Steven Paul Wheeler	Histological specimen treatment apparatus and method
DE102008029356A1 (de)	2008-06-20	2009-12-24	Siemens Healthcare Diagnostics Gmbh	Verfahren zur Aufreinigung von Nukleinsäuren, insbesondere aus fixiertem Gewebe
ES2539856T3 (es)	2008-08-01	2015-07-06	F. Hoffmann-La Roche Ag	Lisis mejorada y transcripción reversa para la cuantificación de mRNA
WO2010065775A2 (en) *	2008-12-03	2010-06-10	The United States Government As Represented By The Department Of Veterans Affairs	Pressure-assisted molecular recovery (pamr) of biomolecules, pressure-assisted antigen retrieval (paar), and pressure-assisted tissue histology (path)
EP2193831A1 (de)	2008-12-05	2010-06-09	Qiagen GmbH	Parallel-Extraktion von unterschiedlichen Biomolekülen aus Formalin-fixiertem Gewebe
DE102008061714A1 (de)	2008-12-12	2010-06-17	Siemens Healthcare Diagnostics Inc., Deerfield	Verfahren zur Aufreinigung von Nukleinsäuren, inbesondere aus fixiertem Gewebe
US8846878B1 (en)	2009-01-23	2014-09-30	Cubrc Corporation	Method and device for isolating a protein sample
EP2210936A1 (en) *	2009-01-27	2010-07-28	Curetis AG	Processing and analysis of viscous liquid biological samples
KR101787768B1 (ko) *	2009-04-18	2017-10-18	제넨테크, 인크.	항-ｃｄ４０ 항체를 사용한 치료에 대한 ｂ-세포 림프종의 반응성 평가를 위한 방법
US20120100997A1 (en)	2009-04-24	2012-04-26	University Of Southern California	Cd133 polymorphisms and expression predict clinical outcome in patients with cancer
DE102009031434B4 (de) *	2009-07-01	2015-03-05	Axagarius Gmbh & Co. Kg	Verwendung eines Kits für die Isolierung von Biomolekülen aus biologischen Proben sowie Kit hierfür
WO2011038019A2 (en)	2009-09-23	2011-03-31	Danisco Us Inc.	Novel glycosyl hydrolase enzymes and uses thereof
US8329360B2 (en)	2009-12-04	2012-12-11	Taiwan Semiconductor Manufacturing Company, Ltd.	Method and apparatus of providing overlay
UA114276C2 (uk)	2009-12-23	2017-05-25	Даніско Юес Інк.	Спосіб одночасного оцукрювання і ферментації
CN102803490B (zh) *	2010-01-04	2015-03-25	奇亚根盖瑟斯堡股份有限公司	用于从固定组织样品回收核酸或蛋白质的方法、组合物和试剂盒
WO2011104027A1 (en) *	2010-02-26	2011-09-01	Qiagen Gmbh	Process for parallel isolation and/or purification of rna and dna
US20190300945A1 (en)	2010-04-05	2019-10-03	Prognosys Biosciences, Inc.	Spatially Encoded Biological Assays
US10787701B2 (en)	2010-04-05	2020-09-29	Prognosys Biosciences, Inc.	Spatially encoded biological assays
EP2556158B1 (en)	2010-04-08	2019-12-18	Qiagen GmbH	Chromatographic device and method for isolating and purifying nucleic acids
US9163228B2 (en)	2010-04-08	2015-10-20	Qiagen Gmbh	Method for isolating and purifying nucleic acids
CN102869790B (zh)	2010-04-12	2014-11-26	反应遗传有限公司	Kras引物和探针
EP2388324A1 (de) *	2010-05-20	2011-11-23	Siemens Healthcare Diagnostics Inc.	Kontrollmaterial für Nukleinsäureteste
EP2395082A1 (en) *	2010-06-14	2011-12-14	QIAGEN GmbH	Extraction of nucleic acids from wax-embedded samples
CN103261873A (zh) *	2010-10-12	2013-08-21	生命科技股份有限公司	制备用于ffpe的质量对照材料的方法
KR101420094B1 (ko) *	2010-10-27	2014-07-17	(주)바이오니아	다양한 생체시료분석을 위한 전자동실시간정량증폭장비, 다양한 생체시료분석을 위한 자동정제 및 반응준비 장치, 전자동 핵산정제 및 실시간 정량 유전자증폭 방법, 전자동 핵산정제방법, 실시간정량ｐｃｒ을 이용한 병원균의 전자동 생균수검사방법, 정량면역ｐｃｒ을 이용한 전자동 항원농도획득방법 및 타겟항원에 라벨링된 부착용 타겟핵산의 정제방법
TWI425977B (zh)	2010-11-24	2014-02-11	Ind Tech Res Inst	將福馬林固定石蠟包埋之組織進行脫蠟的方法與其套組
EP2468862A1 (en) *	2010-12-23	2012-06-27	Qiagen GmbH	Method and kit for processing wax-embedded biological samples
CN102146112B (zh) *	2011-01-25	2013-07-10	天根生化科技（北京）有限公司	从福尔马林固定石蜡包埋组织中提取脱氧核糖核酸的方法
CA2826056C (en) *	2011-02-28	2021-01-26	Dako Denmark A/S	Two phase immiscible system for the pretreatment of embedded biological samples
CN102181431B (zh) *	2011-03-11	2012-12-26	大连医科大学	从石蜡包埋组织中提取总rna的方法
BR112013023757A2 (pt)	2011-03-17	2017-06-06	Danisco Us Inc	método para redução de viscosidade no processo de sacarificação
WO2012135125A1 (en) *	2011-03-28	2012-10-04	Geron Corporation	Telomere length measurement in formalin-fixed, paraffin embedded (ffpe) samples by quantitative pcr
GB201106254D0 (en)	2011-04-13	2011-05-25	Frisen Jonas	Method and product
EP2744916A4 (en)	2011-07-13	2015-06-17	Primeradx Inc	MULTIMODAL METHODS FOR SIMULTANEOUS DETECTION AND QUANTIFICATION OF MULTIPLE NUCLEIC ACIDS IN A SAMPLE
FR2982278A1 (fr)	2011-11-03	2013-05-10	Assist Publ Hopitaux De Paris	Procede de classification d'echantillons de tissus fixes et inclus en paraffine
US9416357B2 (en)	2011-11-16	2016-08-16	University Of Georgia Research Foundation, Inc.	Method for isolating total RNA from cells
WO2013074885A1 (en)	2011-11-17	2013-05-23	Rheonix, Inc.	Microfluidic apparatus, method, and applications
CN103571824B (zh)	2012-08-09	2016-04-13	财团法人工业技术研究院	用于分离核酸的组合物及方法
EP2900819B1 (en)	2012-09-28	2020-10-28	Cepheid	Methods for dna and rna extraction from fixed paraffin-embedded tissue samples
EP2906703A2 (en)	2012-10-15	2015-08-19	Pioneer Hi-Bred International, Inc.	Methods and compositions to enhance activity of cry endotoxins
DK3511423T4 (da)	2012-10-17	2024-07-29	Spatial Transcriptomics Ab	Fremgangsmåder og produkt til optimering af lokaliseret eller rumlig detektion af genekspression i en vævsprøve
US10968446B2 (en)	2012-11-01	2021-04-06	Massachusetts Institute Of Technology	Directed evolution of synthetic gene cluster
EP2730653A1 (en)	2012-11-07	2014-05-14	QIAGEN GmbH	Method for lysing a fixed biological sample
US9200327B2 (en)	2012-11-30	2015-12-01	Geron Corporation	Diagnostic markers for treating cell proliferative disorders with telomerase inhibitors
EP2970363B1 (en)	2013-03-14	2020-07-08	Pioneer Hi-Bred International, Inc.	Compositions and methods to control insect pests
US10023877B2 (en)	2013-03-15	2018-07-17	Pioneer Hi-Bred International, Inc.	PHI-4 polypeptides and methods for their use
KR101748867B1 (ko) *	2013-04-19	2017-06-20	주식회사 젠큐릭스	조기 유방암 예후 예측 진단용 자동화 시스템
CA2916660C (en)	2013-06-25	2022-05-17	Prognosys Biosciences, Inc.	Spatially encoded biological assays using a microfluidic device
EP3032942B1 (en)	2013-08-16	2020-03-11	Pioneer Hi-Bred International, Inc.	Insecticidal proteins and methods for their use
MX359027B (es)	2013-09-13	2018-09-12	Pioneer Hi Bred Int	Proteinas insecticidas y metodos para su uso.
CN114763376A (zh)	2014-02-07	2022-07-19	先锋国际良种公司	杀昆虫蛋白及其使用方法
RU2747978C2 (ru)	2014-02-07	2021-05-18	Пайонир Хай-Бред Интернэшнл, Инк.	Инсектицидные белки и способы их применения
WO2016000237A1 (en)	2014-07-03	2016-01-07	Pioneer Overseas Corporation	Plants having enhanced tolerance to insect pests and related constructs and methods involving insect tolerance genes
WO2016044092A1 (en)	2014-09-17	2016-03-24	Pioneer Hi Bred International Inc	Compositions and methods to control insect pests
MX2017004745A (es)	2014-10-16	2017-10-20	Pioner Hi-Bred Int Inc	Proteinas insecticidas y metodos de uso.
DE102014118532B4 (de)	2014-12-12	2017-03-23	Axagarius Gmbh & Co. Kg	Vorrichtung mit einer Filterschicht und Verfahren zur Gewinnung von Nukleinsäuren aus Formalin-fixierten und in Paraffin eingebetteten Proben
US10968443B2 (en) *	2014-12-31	2021-04-06	The Rockefeller University	Method of RNA isolation from clinical samples
WO2016144688A1 (en)	2015-03-11	2016-09-15	Pioneer Hi Bred International Inc	Insecticidal combinations of pip-72 and methods of use
JP6828007B2 (ja)	2015-04-10	2021-02-10	スペーシャルトランスクリプトミクスアクチボラグ	生物学的試料の空間識別されるマルチプレックスな核酸分析
US10365189B2 (en)	2015-05-07	2019-07-30	Steven Wheeler	Histological specimen treatment
CN116333064A (zh)	2015-05-19	2023-06-27	先锋国际良种公司	杀昆虫蛋白及其使用方法
EA033170B1 (ru) *	2015-05-21	2019-09-30	Государственное Учреждение Образования "Белорусская Медицинская Академия Последипломного Образования" (Гуо "Белмапо")	Способ определения экспрессии гена gstm1 в образцах из парафин-фиксированных срезов опухолевой ткани молочной железы
MX2017016119A (es)	2015-06-16	2018-03-07	Pioneer Hi Bred Int	Composiciones y metodos para controlar plagas de insectos.
KR20230152796A (ko)	2015-07-13	2023-11-03	피벗 바이오, 인크.	식물 형질 개선을 위한 방법 및 조성물
EP3705582A1 (en)	2015-07-24	2020-09-09	Cepheid	Compositions and methods for dna and rna extraction from tissue samples
WO2017023486A1 (en)	2015-08-06	2017-02-09	Pioneer Hi-Bred International, Inc.	Plant derived insecticidal proteins and methods for their use
ES2773072T3 (es)	2015-08-28	2020-07-09	Pioneer Hi Bred Int	Transformación de plantas mediada por Ochrobactrum
US11479516B2 (en)	2015-10-05	2022-10-25	Massachusetts Institute Of Technology	Nitrogen fixation using refactored NIF clusters
KR101749419B1 (ko)	2015-10-15	2017-07-03	주식회사 어큐진	파라핀포매된 샘플로부터 dna를 추출하는 방법
CN108449995B (zh)	2015-11-06	2022-02-01	文塔纳医疗系统公司	代表性诊断
EP3390431A1 (en)	2015-12-18	2018-10-24	Pioneer Hi-Bred International, Inc.	Insecticidal proteins and methods for their use
BR112018070754A2 (pt)	2016-04-14	2019-02-12	Pioneer Hi-Bred International, Inc.	polipeptídeos, polinucleotídeos, construção de dna, célula hospedeira, plantas ou célula vegetal, semente, composição, método para controlar uma população de pragas lepidópteras, método para exterminar uma praga de lepidóptero, método para produzir um polipeptídeo com atividade pesticida e método para proteger uma planta contra uma praga de inseto
EP3445861B1 (en)	2016-04-19	2021-12-08	Pioneer Hi-Bred International, Inc.	Insecticidal combinations of polypeptides having improved activity spectrum and uses thereof
EP3451837B1 (en)	2016-05-04	2021-08-25	Pioneer Hi-Bred International, Inc.	Insecticidal proteins and methods for their use
WO2017218207A1 (en)	2016-06-16	2017-12-21	Pioneer Hi-Bred International, Inc.	Compositions and methods to control insect pests
CN116334123A (zh)	2016-06-24	2023-06-27	先锋国际良种公司	植物调节元件及其使用方法
MX2018015906A (es)	2016-07-01	2019-04-04	Pioneer Hi Bred Int	Proteinas insecticidas de plantas y metodos para sus usos.
WO2018013333A1 (en)	2016-07-12	2018-01-18	Pioneer Hi-Bred International, Inc.	Compositions and methods to control insect pests
CN109863167B (zh)	2016-11-01	2022-12-23	先锋国际良种公司	杀昆虫蛋白及其使用方法
WO2018111551A1 (en)	2016-12-14	2018-06-21	Pioneer Hi-Bred International, Inc.	Insecticidal proteins and methods for their use
CA3046226A1 (en)	2016-12-22	2018-06-28	Pioneer Hi-Bred International, Inc.	Insecticidal proteins and methods for their use
EP3559271A1 (en)	2016-12-22	2019-10-30	Ventana Medical Systems, Inc.	Fully automated nucleic acid extraction method for tissue samples
KR102698684B1 (ko)	2017-01-12	2024-08-27	피벗 바이오, 인크.	식물 형질 개선을 위한 방법 및 조성물
WO2018140214A1 (en)	2017-01-24	2018-08-02	Pioneer Hi-Bred International, Inc.	Nematicidal protein from pseudomonas
MX2019009371A (es)	2017-02-08	2019-09-23	Pionner Hi Bred Int Inc	Combinaciones insecticidas de proteinas insecticidas derivadas de plantas y metodos para su uso.
EA201992824A1 (ru)	2017-05-26	2020-05-06	Пайонир Хай-Бред Интернэшнл, Инк.	Инсектицидные полипептиды, обладающие улучшенным спектром активности, и пути их применения
CN107271239A (zh) *	2017-07-06	2017-10-20	浙江大学	一种溶解石蜡组织切片的方法及应用
WO2019074598A1 (en)	2017-10-13	2019-04-18	Pioneer Hi-Bred International, Inc.	VIRUS-INDUCED GENETIC SILENCING TECHNOLOGY FOR THE CONTROL OF INSECTS IN MAIZE
EP3701040A4 (en)	2017-10-25	2021-08-25	Pivot Bio, Inc.	METHODS AND COMPOSITIONS FOR IMPROVING GENETICALLY MODIFIED MICROBES THAT BIND NITROGEN
KR20200123144A (ko)	2018-02-22	2020-10-28	지머젠 인코포레이티드	바실러스가 농축된 게놈 라이브러리를 생성하고 새로운 cry 독소를 동정하기 위한 방법
WO2019169150A1 (en)	2018-03-02	2019-09-06	Pioneer Hi-Bred International, Inc.	Plant health assay
BR112020017975A2 (pt)	2018-03-02	2020-12-29	Zymergen Inc.	Plataforma de descoberta de proteína inseticida e proteínas inseticidas descobertas a partir da mesma
MX2020009435A (es)	2018-03-14	2020-11-11	Pioneer Hi Bred Int	Proteinas con actividad insecticida de plantas y metodos para sus usos.
WO2019178038A1 (en)	2018-03-14	2019-09-19	Pioneer Hi-Bred International, Inc.	Insecticidal proteins from plants and methods for their use
US11702668B2 (en)	2018-05-22	2023-07-18	Pioneer Hi-Bred International, Inc.	Plant regulatory elements and methods of use thereof
CA3103977A1 (en)	2018-06-27	2020-01-02	Pivot Bio, Inc.	Agricultural compositions comprising remodeled nitrogen fixing microbes
MX2021002290A (es)	2018-08-29	2021-04-28	Pioneer Hi Bred Int	Proteinas insecticidas y metodos para su uso.
US20220049294A1 (en)	2018-12-10	2022-02-17	10X Genomics, Inc.	Imaging system hardware
US11649485B2 (en)	2019-01-06	2023-05-16	10X Genomics, Inc.	Generating capture probes for spatial analysis
US11926867B2 (en)	2019-01-06	2024-03-12	10X Genomics, Inc.	Generating capture probes for spatial analysis
WO2020243579A1 (en)	2019-05-30	2020-12-03	10X Genomics, Inc.	Methods of detecting spatial heterogeneity of a biological sample
CN110376036A (zh) *	2019-07-30	2019-10-25	河南赛诺特生物技术有限公司	一种肿瘤细胞系免疫组化对照品的制备方法及肿瘤细胞系免疫组化对照品
CN110361242B (zh) *	2019-08-14	2022-01-18	武汉赛维尔生物科技有限公司	一种用于眼球组织的固定液以及眼球组织制片的预处理方法
WO2021076346A1 (en)	2019-10-18	2021-04-22	Pioneer Hi-Bred International, Inc.	Maize event dp-202216-6 and dp-023211-2 stack
WO2021092433A2 (en)	2019-11-08	2021-05-14	10X Genomics, Inc.	Enhancing specificity of analyte binding
WO2021133845A1 (en)	2019-12-23	2021-07-01	10X Genomics, Inc.	Reversible fixing reagents and methods of use thereof
SG11202106899SA (en)	2019-12-23	2021-09-29	10X Genomics Inc	Methods for spatial analysis using rna-templated ligation
US20210190770A1 (en)	2019-12-23	2021-06-24	10X Genomics, Inc.	Compositions and methods for using fixed biological samples in partition-based assays
US11702693B2 (en)	2020-01-21	2023-07-18	10X Genomics, Inc.	Methods for printing cells and generating arrays of barcoded cells
US11732299B2 (en)	2020-01-21	2023-08-22	10X Genomics, Inc.	Spatial assays with perturbed cells
US12076701B2 (en)	2020-01-31	2024-09-03	10X Genomics, Inc.	Capturing oligonucleotides in spatial transcriptomics
US11898205B2 (en)	2020-02-03	2024-02-13	10X Genomics, Inc.	Increasing capture efficiency of spatial assays
US12110541B2 (en)	2020-02-03	2024-10-08	10X Genomics, Inc.	Methods for preparing high-resolution spatial arrays
TW202142114A (zh)	2020-02-04	2021-11-16	美商陶氏農業科學公司	具有殺有害生物效用之組成物及與其相關之方法
US11732300B2 (en)	2020-02-05	2023-08-22	10X Genomics, Inc.	Increasing efficiency of spatial analysis in a biological sample
WO2021158925A1 (en)	2020-02-07	2021-08-12	10X Genomics, Inc.	Quantitative and automated permeabilization performance evaluation for spatial transcriptomics
US11891654B2 (en)	2020-02-24	2024-02-06	10X Genomics, Inc.	Methods of making gene expression libraries
JP2023521579A (ja)	2020-03-31	2023-05-25	キアゲンゲーエムベーハー	固定された生体試料からの核酸精製
WO2021207610A1 (en)	2020-04-10	2021-10-14	10X Genomics, Inc.	Cold protease treatment method for preparing biological samples
CN115916972A (zh)	2020-04-16	2023-04-04	10X基因组学有限公司	用于被固定样品的组合物和方法
EP4139485B1 (en)	2020-04-22	2023-09-06	10X Genomics, Inc.	Methods for spatial analysis using targeted rna depletion
EP4153776A1 (en)	2020-05-22	2023-03-29	10X Genomics, Inc.	Spatial analysis to detect sequence variants
EP4414459A3 (en)	2020-05-22	2024-09-18	10X Genomics, Inc.	Simultaneous spatio-temporal measurement of gene expression and cellular activity
US12031177B1 (en)	2020-06-04	2024-07-09	10X Genomics, Inc.	Methods of enhancing spatial resolution of transcripts
ES2981265T3 (es)	2020-06-08	2024-10-08	10X Genomics Inc	Métodos para determinar un margen quirúrgico y métodos de uso del mismo
WO2021263111A1 (en)	2020-06-25	2021-12-30	10X Genomics, Inc.	Spatial analysis of dna methylation
US11761038B1 (en)	2020-07-06	2023-09-19	10X Genomics, Inc.	Methods for identifying a location of an RNA in a biological sample
US11981960B1 (en)	2020-07-06	2024-05-14	10X Genomics, Inc.	Spatial analysis utilizing degradable hydrogels
EP4182466A2 (en)	2020-07-14	2023-05-24	Pioneer Hi-Bred International, Inc.	Insecticidal proteins and methods for their use
CN116323968A (zh)	2020-07-31	2023-06-23	10X基因组学有限公司	用于空间分析的去交联化合物和使用方法
WO2022035649A1 (en)	2020-08-10	2022-02-17	Pioneer Hi-Bred International, Inc.	Plant regulatory elements and methods of use thereof
US11981958B1 (en)	2020-08-20	2024-05-14	10X Genomics, Inc.	Methods for spatial analysis using DNA capture
US11926822B1 (en)	2020-09-23	2024-03-12	10X Genomics, Inc.	Three-dimensional spatial analysis
EP4244379A1 (en)	2020-11-13	2023-09-20	10X Genomics, Inc.	Nano-partitions (encapsulated nucleic acid processing enzymes) for cell-lysis and multiple reactions in partition-based assays
US11827935B1 (en)	2020-11-19	2023-11-28	10X Genomics, Inc.	Methods for spatial analysis using rolling circle amplification and detection probes
WO2022140028A1 (en)	2020-12-21	2022-06-30	10X Genomics, Inc.	Methods, compositions, and systems for capturing probes and/or barcodes
CN114854824A (zh) *	2021-02-03	2022-08-05	深圳华大基因股份有限公司	建库方法及应用
EP4347879A1 (en)	2021-06-03	2024-04-10	10X Genomics, Inc.	Methods, compositions, kits, and systems for enhancing analyte capture for spatial analysis
US20230071935A1 (en) *	2021-08-25	2023-03-09	Matchstick Technologies, Inc.	Microplate cycling thermo sonicator with programmable ultrasound, heating, and cooling for multi-analytical applications
WO2023034489A1 (en)	2021-09-01	2023-03-09	10X Genomics, Inc.	Methods, compositions, and kits for blocking a capture probe on a spatial array
TW202345696A (zh)	2022-05-18	2023-12-01	美商科迪華農業科技有限責任公司	具有殺有害生物效用之組成物及與其相關的方法
WO2023245190A1 (en)	2022-06-17	2023-12-21	10X Genomics, Inc.	Catalytic de-crosslinking of samples for in situ analysis

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4830969A (en)	1981-08-31	1989-05-16	The Research Foundation Of State University Of New York	Process for the rapid and simple isolation of nucleic acids
US4843155A (en)	1987-11-19	1989-06-27	Piotr Chomczynski	Product and process for isolating RNA
US5128247A (en)	1989-08-14	1992-07-07	Board Of Regents, The University Of Texas System	Methods for isolation of nucleic acids from eukaryotic and prokaryotic sources
US5284940A (en)	1990-11-14	1994-02-08	Hri Research, Inc.	Preparation for nucleic acid samples
US5620852A (en)	1990-11-14	1997-04-15	Hri Research, Inc.	Nucleic acid preparation methods
US5654179A (en) *	1990-11-14	1997-08-05	Hri Research, Inc.	Nucleic acid preparation methods
US5346994A (en) *	1992-01-28	1994-09-13	Piotr Chomczynski	Shelf-stable product and process for isolating RNA, DNA and proteins
US5502166A (en)	1992-02-26	1996-03-26	Mitsubishi Chemical Corporation	NMDH receptor proteins and genes encoding the same
AU6230594A (en)	1993-02-01	1994-08-29	University Of Iowa Research Foundation, The	Quartenary amine surfactants and methods of using same in isolation of rna
US5876978A (en) *	1993-04-06	1999-03-02	Medical College Of Ohio	Method for quantitative measurement of gene expression using multiplex competitive reverse transcriptase-polymerase chain reaction
US5637687A (en)	1993-08-31	1997-06-10	Wiggins; James C.	Methods and compositions for isolating nucleic acids
US5643767A (en)	1994-05-02	1997-07-01	The Rockefeller University	Process for isolating cellular components
US5942391A (en) *	1994-06-22	1999-08-24	Mount Sinai School Of Medicine	Nucleic acid amplification method: ramification-extension amplification method (RAM)
US5876924A (en) *	1994-06-22	1999-03-02	Mount Sinai School Of Medicine	Nucleic acid amplification method hybridization signal amplification method (HSAM)
CA2153215A1 (en)	1994-07-06	1996-01-07	Lu Wang	Treatment of paraffin embedded tissue for gene analysis
US5763169A (en) *	1995-01-13	1998-06-09	Chiron Diagnostics Corporation	Nucleic acid probes for the detection and identification of fungi
US5707802A (en) *	1995-01-13	1998-01-13	Ciba Corning Diagnostics Corp.	Nucleic acid probes for the detection and identification of fungi
US5777099A (en)	1995-02-24	1998-07-07	Biotecx Laboratories, Inc.	RNA separation
US5945515A (en)	1995-07-31	1999-08-31	Chomczynski; Piotr	Product and process for isolating DNA, RNA and proteins
US5998151A (en)	1995-12-01	1999-12-07	The United States Of America As Represented By The Department Of Health And Human Services	Methods for predicting the efficacy of a chemotherapeutic regimen for gastrointestinal cancers using antibodies specific for thymidylate synthase
US20020090642A1 (en) *	1995-12-11	2002-07-11	Patrick G. Johnston	Methods for determining the prognosis of breast cancer using antibodies specific for thymidylate synthase
DE29601618U1 (de)	1996-01-31	1996-07-04	InViTek GmbH, 13125 Berlin	Vorrichtung zur gleichzeitigen multiplen Isolierung
EP0791654A1 (en)	1996-02-21	1997-08-27	Jürgen A. Dr. Richt	Polypeptides corresponding to the amino acid sequences of proteins p57 or p9.5 of Borna disease virus, nucleic acid fragments coding therefore and their use for diagnostic and immunization purposes
EP0912726A4 (en) *	1996-05-10	2001-07-18	Phylomed Corp	METHODS FOR OXIDIZING BISULFIDE LINKS WITH OZONE
CA2284686A1 (en) *	1997-03-31	1998-10-08	Abbott Laboratories	Reagents and methods useful for detecting diseases of the gastrointestinal tract
CA2366231C (en) *	1999-03-18	2010-05-11	Exiqon A/S	One step sample preparation and detection of nucleic acids in complex biological samples
US6248535B1 (en) *	1999-12-20	2001-06-19	University Of Southern California	Method for isolation of RNA from formalin-fixed paraffin-embedded tissue specimens

1999
- 1999-12-20 US US09/469,338 patent/US6248535B1/en not_active Expired - Lifetime
2000
- 2000-10-31 EA EA200501772A patent/EA008832B1/ru not_active IP Right Cessation
- 2000-10-31 MX MXPA02006145A patent/MXPA02006145A/es active IP Right Grant
- 2000-10-31 AU AU15785/01A patent/AU784565C/en not_active Ceased
- 2000-10-31 DK DK06123097.5T patent/DK1743939T3/da active
- 2000-10-31 CN CNB008174741A patent/CN1269959C/zh not_active Expired - Fee Related
- 2000-10-31 AT AT00978311T patent/ATE349518T1/de active
- 2000-10-31 ES ES06123097T patent/ES2373149T3/es not_active Expired - Lifetime
- 2000-10-31 CA CA2394618A patent/CA2394618C/en not_active Expired - Fee Related
- 2000-10-31 IL IL15011600A patent/IL150116A0/xx unknown
- 2000-10-31 EP EP06123097A patent/EP1743939B1/en not_active Expired - Lifetime
- 2000-10-31 EP EP00978311A patent/EP1242594B1/en not_active Expired - Lifetime
- 2000-10-31 DE DE60032634T patent/DE60032634T2/de not_active Expired - Lifetime
- 2000-10-31 EA EA200200698A patent/EA006827B1/ru not_active IP Right Cessation
- 2000-10-31 CN CN200610093878XA patent/CN1891836B/zh not_active Expired - Fee Related
- 2000-10-31 JP JP2001546900A patent/JP2003525033A/ja active Pending
- 2000-10-31 WO PCT/US2000/030012 patent/WO2001046402A1/en active IP Right Grant
- 2000-10-31 KR KR1020027007849A patent/KR100723328B1/ko not_active IP Right Cessation
- 2000-10-31 AT AT06123097T patent/ATE523590T1/de active
- 2000-10-31 BR BR0016569-7A patent/BR0016569A/pt not_active Application Discontinuation
- 2000-10-31 EP EP10182481.1A patent/EP2363477A3/en not_active Withdrawn
- 2000-12-20 TW TW089127378A patent/TWI277652B/zh not_active IP Right Cessation
- 2000-12-20 AR ARP000106793A patent/AR027036A1/es active IP Right Grant
2001
- 2001-03-01 US US09/797,158 patent/US6428963B2/en not_active Expired - Lifetime
- 2001-03-01 US US09/797,163 patent/US6610488B2/en not_active Expired - Lifetime
- 2001-03-01 US US09/797,216 patent/US6613518B2/en not_active Expired - Lifetime
2002
- 2002-06-10 IL IL150116A patent/IL150116A/en not_active IP Right Cessation
- 2002-06-19 NO NO20022945A patent/NO330802B1/no not_active IP Right Cessation
2003
- 2003-07-08 US US10/616,203 patent/US20040091910A1/en not_active Abandoned
- 2003-07-30 US US10/631,413 patent/US7960147B2/en not_active Expired - Fee Related
- 2003-10-28 HK HK03107749A patent/HK1055446A1/xx not_active IP Right Cessation
2006
- 2006-04-05 US US11/278,804 patent/US7998707B2/en not_active Expired - Fee Related
- 2006-07-12 AU AU2006202986A patent/AU2006202986B2/en not_active Ceased
2007
- 2007-04-26 HK HK07104456.2A patent/HK1098178A1/xx not_active IP Right Cessation
- 2007-07-27 US US11/881,625 patent/US7919280B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US7998707B2 (en)	2011-08-16
US6428963B2 (en)	2002-08-06
EP1743939B1 (en)	2011-09-07
CN1269959C (zh)	2006-08-16
EA008832B1 (ru)	2007-08-31
US20020009795A1 (en)	2002-01-24
US7919280B2 (en)	2011-04-05
WO2001046402A1 (en)	2001-06-28
TWI277652B (en)	2007-04-01
IL150116A0 (en)	2002-12-01
EP2363477A3 (en)	2013-07-31
AU2006202986B2 (en)	2008-12-04
AU784565B2 (en)	2006-05-04
DE60032634D1 (de)	2007-02-08
US20040091910A1 (en)	2004-05-13
CA2394618C (en)	2013-05-07
US20040018551A1 (en)	2004-01-29
DE60032634T2 (de)	2007-10-04
US20010029018A1 (en)	2001-10-11
US6248535B1 (en)	2001-06-19
CN1891836B (zh)	2010-04-21
KR100723328B1 (ko)	2007-05-31
DK1743939T3 (da)	2011-12-12
US20090035761A1 (en)	2009-02-05
US20060199197A1 (en)	2006-09-07
EP2363477A2 (en)	2011-09-07
US20020009794A1 (en)	2002-01-24
IL150116A (en)	2012-01-31
AU1578501A (en)	2001-07-03
AU784565C (en)	2007-02-01
US6610488B2 (en)	2003-08-26
JP2003525033A (ja)	2003-08-26
US7960147B2 (en)	2011-06-14
EP1242594A1 (en)	2002-09-25
CN1420927A (zh)	2003-05-28
EA006827B1 (ru)	2006-04-28
MXPA02006145A (es)	2004-08-23
AR027036A1 (es)	2003-03-12
ES2373149T3 (es)	2012-01-31
BR0016569A (pt)	2003-07-15
US6613518B2 (en)	2003-09-02
EP1743939A3 (en)	2007-05-09
EP1242594B1 (en)	2006-12-27
EP1743939A2 (en)	2007-01-17
EA200200698A1 (ru)	2003-12-25
AU2006202986A1 (en)	2006-08-10
HK1055446A1 (en)	2004-01-09
CN1891836A (zh)	2007-01-10
CA2394618A1 (en)	2001-06-28
EA200501772A1 (ru)	2006-10-27
HK1098178A1 (en)	2007-07-13
NO20022945D0 (no)	2002-06-19
ATE523590T1 (de)	2011-09-15
NO20022945L (no)	2002-08-06
KR20030027878A (ko)	2003-04-07
ATE349518T1 (de)	2007-01-15

Publication	Publication Date	Title
NO330802B1 (no)	2011-07-18	Metode for gjenvinning av RNA fra formalin-fiksert paraffin-innstopt vevsprove, metode for kvantitativ maling av genekspresjon av et malgen og metode for maling av niva av malgenekspresjon i en fiksert paraffin-innstopt vevsprove.
US11965156B2 (en)	2024-04-23	RNA isolation from soluble urine fractions
US20140308670A1 (en)	2014-10-16	Simultaneous extraction of dna and rna from ffpe tissues
CA2626533C (en)	2013-03-19	Method for the isolation of mrna from formalin fixed, paraffin-embedded tissue
CN111278844B (zh)	2023-12-19	用于使用氧化铁颗粒提取核酸的方法和组合物

Legal Events

Date	Code	Title	Description
2015-05-26	MM1K	Lapsed by not paying the annual fees